Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
Nikkei edges down to 22,192 on receding U.S.-China trade worries

2018-08-16 japantimes.co.jp
The key Nikkei average closed marginally lower Thursday after cutting most of its early loss thanks to receding worries about U.S.-China trade friction.
5406 KBSTF KBSTY MRAAF MRAAY

0
Tokyo stocks jump on Wall Street gain, weaker yen

2018-08-01 japantimes.co.jp
Stocks rose sharply on the Tokyo Stock Exchange on Wednesday, with investor sentiment bolstered by an overnight rise in U.S. equities and a weaker yen.
KYO MRAAF 5411 MRAAY JFEEF

0
Tokyo stocks rise further on brisk U.S. and European markets

2018-07-25 japantimes.co.jp
Stocks extended gains on the Tokyo Stock Exchange on Wednesday, with investor sentiment brightened by overnight rises in U.S. and European equities.
6755 MRAAF FGELF MRAAY

2
Nikkei falls sharply on stronger yen

2018-07-23 japantimes.co.jp
The Nikkei 225 gave up 300.89 points, or 1.33 percent, to end at 22,396.99. The key market gauge sagged 66.80 points Friday.
TM SMFG TYT MRAAY SFTBF TOYOF SMFNF TOELY 8316 MRAAF 8306 7203 MUFG 9984 8750 8035 TOELF MBFJF SFTBY MTU

0
Japanese stocks stumble, spooked by yuan's fall

2018-07-20 reuters
TOKYO, July 20 (Reuters) - Japanese stocks dropped on Friday as an extended decline in the Chinese yuan rekindled worries about the stability of the Chinese economy which faces rising risks from a major trade conflict with the United States
5406 KBSTF KBSTY MRAAF MRAAY

0
Tokyo stocks open higher with yen stable against dollar

2018-07-09 bworldonline
Tokyo stocks opened higher on Monday, extending rallies in New York with the cheaper yen also supporting the market.
MRAAF MRAAY

0
Nikkei hits 3-month low on trade war fears

2018-07-03 thehindubusinessline
Nikkei average ended the morning trade almost flat at 21,805.73, having dropped 0.4 per cent at one point to 21,722.23, its lowest level since mid-April.
MRAAF MRAAY

2
Nikkei dives below 22,000 on futures-led selling

2018-07-02 japantimes.co.jp
Stocks turned sharply lower Monday, battered by futures-led selling, with the Nikkei 225 average closing below 22,000 for the first time in more than two months.
MRAAF MRAAY 9984 SFTBF SFTBY

0
Nikkei edges up after buying on dips counters weak opening

2018-06-26 japantimes.co.jp
Stocks ended slightly higher on Tuesday after wiping out early losses thanks to buying on dips.
MRAAF MRAAY

0
Nikkei sheds 401 points on U.S.-China trade war fears

2018-06-19 japantimes.co.jp
Stocks plunged on the Tokyo Stock Exchange Tuesday amid growing concerns about a trade war developing between the United States and China.
MRAAF MRAAY TSUSF 3391

6
Nikkei rises on ECB decision; chip-related shares tumble

2018-06-15 thehindubusinessline
Japan's Nikkei share average rose on Friday morning after the European Central Bank announced it would avoid raising rates until mid-2019, but chip-related stocks tumbled after a brokerage slashed the target price of Tokyo Electron.
4503 ALPMY ADTTF ALPMF MRAAF MRAAY 8035 TOELF ATEYY TOELY

3
Sypris Keeps Delivering

2018-06-06 seekingalpha - 1
Sypris Solutions Inc (SYPR) operates in the defense, oil & gas and trucks segments, all of which have been experiencing good momentum under the presidency of Trump. So why has SYPR´s stock stayed flat while the industry has witnessed returns of 30%-50% during the last twelve months? In this article, I will provide some insight on why I think that is happening, an update on SYPR, the industry and the valuation.
SYPR MRAAF MRAAY

158
Tokyo stocks end higher on futures-led buying

2018-06-06 japantimes.co.jp
The 225-issue Nikkei average added 86.19 points, or 0.38 percent, to end at 22,625.73. On Tuesday, the key market gauge gained 63.60 points.
KYO MRAAF AAPL MRAAY 9984 SFTBF SFTBY

4
Tokyo stocks edge up amid lack of trading incentives

2018-06-05 japantimes.co.jp
The Nikkei 225 average rose 63.60 points, or 0.28 percent, to end at 22,539.54 after jumping 304.59 points on Monday.
5406 KBSTF KBSTY MRAAF MRAAY 9984 SFTBF 8035 TOELF SFTBY TOELY

Related Articles

REPH: Recro Pharma Analysis and Research Report

23h - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

23h - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...

CUSIP: 626425102